MEDTRONIC PUERTO RICO OPERATIONS CO. SYNCHROMED II PUMP, INFUSION, IMPLANTED, PROGRAMMABLE
|
Back to Search Results |
|
Model Number 8637-40 |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Abdominal Pain (1685); Diarrhea (1811); Low Blood Pressure/ Hypotension (1914); Pain (1994); Therapeutic Effects, Unexpected (2099); Therapeutic Response, Decreased (2271)
|
Event Date 03/23/2020 |
Event Type
Injury
|
Manufacturer Narrative
|
Concomitant medical products: product id: 8598a, serial#: (b)(4), implanted: (b)(6) 2018, product type: catheter.
Product id: 85 96sc, serial# (b)(4), implanted: (b)(6) 2018, product type: catheter.
If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Information was received from a healthcare professional (hcp) via a clinical study regarding a patient with an implantable pump for non-malignant pain.
Per the session report from 2020-feb-06, the pump administered the following medications as of (b)(6) 2019: fentanyl (concentration: 2000 mcg, dose rate: 900.
09156 mcg/day), bupivacaine (concentration: 20 mg, dose rate: 9.
00092 mg/day), and morphine (concentration: 5.
8 mg, dose rate: 2.
61027 mg/day).
It was reported that the patient indicated that over the past 6 weeks, a gradual increase in pain had occurred.
The date (b)(6) 2020 is considered an approximate date of event (specific month and year known only).
It was further noted that the patient had been in and out of the hospital due to diarrhea, hypotension and abdominal pain.
The patient didn¿t feel boluses and possible withdrawals was further noted.
The programming date from the most recent refill prior to event occurred on (b)(6) 2020.
The clinical diagnosis was increase in pain.
The date of test was (b)(6) 2020.
A catheter access port (cap) contrast study on (b)(6) 2020 revealed normal catheter function.
Actions taken to resolve the issue included reprogramming and an increase in fentanyl occurred on (b)(6) 2020.
The event resulted in-patient hospitalization.
Regarding etiology, it was indicated that the relationship of the event to the device or therapy was possibly related and it was indicated that there was no change in drug.
The event was noted as not having been related to the implant procedure.
The event was ongoing.
No further patient complications have been reported as a result of this event.
|
|
Search Alerts/Recalls
|
|
|